Yuma Regional Medical Center

Yuma Regional Medical Center was paid $278.42M by Medicaid between Jan 2018 and Dec 2024, across 970 billing codes. Its largest line is 99284, emergency room visit (serious) — 9.6% of everything it billed.

33Billing provider infoYUMA REGIONAL MEDICAL CENTER
YUMA, AZ 85364

33aNPI1194706655assigned 11/10/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$278.42M

24GClaims6,876,263

24DCodes billed970

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Arizona

Rank by total paid#1 of 78

Median peer was paid$12.21M

This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	723,955	$29.01M
2019	786,813	$33.13M
2020	740,322	$31.29M
2021	941,235	$41.27M
2022	1,164,601	$45.58M
2023	1,333,969	$52.24M
2024incomplete	1,185,368	$45.89M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.6%	85,860	76,359	$26.61M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	9.1%	390,685	307,935	$25.35M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.4%	94,932	86,878	$23.33M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.8%	22,908	20,352	$13.37M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.7%	33,163	31,433	$13.06M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.9%	169,835	157,466	$8.02M
T1015	A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive	2.7%	17,546	13,619	$7.43M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.5%	192,763	178,556	$6.89M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.9%	27,396	10,746	$5.25M
47562		1.7%	1,262	1,235	$4.62M
J9271	Injection, pembrolizumab, 1 mg	1.5%	501	382	$4.28M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.5%	23,529	21,518	$4.18M

958 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	13,014	$4.13M
77067	Screening mammography, bilateral, including computer-aided detection	1.3%	41,404	$3.68M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.2%	877	$3.33M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.2%	13,369	$3.21M
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.1%	4,948	$3.05M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	45,025	$2.82M
27447		<1%	866	$2.61M
47563		<1%	527	$2.54M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	20,545	$2.39M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	6,242	$2.18M
93458		<1%	1,379	$2.15M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	9,707	$1.90M
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	30,772	$1.86M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	59,173	$1.84M
70450	Computed tomography, head or brain; without contrast material	<1%	33,227	$1.70M
58661		<1%	317	$1.69M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	3,189	$1.67M
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	1,676	$1.65M
76641		<1%	16,008	$1.64M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	5,369	$1.46M
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	1,125	$1.44M
20611		<1%	10,855	$1.43M
49083		<1%	5,901	$1.41M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	63,062	$1.41M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	43,789	$1.36M
99232	Hospital visit by a doctor, follow-up day	<1%	34,593	$1.36M
99203	Doctor's office visit, new patient (routine)	<1%	28,093	$1.35M
72125	Computed tomography, cervical spine; without contrast material	<1%	9,550	$1.31M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	15,295	$1.30M
19083		<1%	1,066	$1.24M
76819	Fetal biophysical profile; without non-stress testing	<1%	10,333	$1.24M
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	21,495	$1.22M
99204	Doctor's office visit, new patient (more involved)	<1%	17,034	$1.20M
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	16,584	$1.17M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	29,936	$1.14M
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	11,236	$1.14M
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	5,145	$1.13M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	14,395	$1.12M
01967	Neuraxial labor analgesia/anesthesia for planned vaginal delivery	<1%	2,254	$1.10M
92587		<1%	5,609	$1.10M
11045		<1%	3,448	$1.08M
59025	Fetal non-stress test	<1%	30,604	$1.03M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	13,110	$1.02M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,021	$1.02M
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	8,882	$976K
84439		<1%	26,838	$954K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	92,270	$921K
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,451	$870K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	262	$840K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	14,407	$822K
G0378	Hospital observation service, per hour	<1%	68,728	$815K
20610		<1%	5,421	$811K
71046	Radiologic examination, chest; 2 views	<1%	54,770	$810K
80053	Comprehensive metabolic panel	<1%	212,299	$782K
99239	Hospital discharge day management, more than 30 minutes	<1%	12,905	$759K
58558		<1%	394	$740K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	9,892	$721K
99215	Doctor's office visit, returning patient (complex)	<1%	11,164	$689K
99460		<1%	9,701	$680K
36902		<1%	944	$678K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	10,672	$672K
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,410	$656K
77080		<1%	12,635	$654K
99222	Initial hospital care, per day, moderate complexity	<1%	8,707	$650K
C1776	Joint device (implantable)	<1%	697	$649K
76536		<1%	9,203	$606K
74178		<1%	2,019	$593K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	415	$590K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	82,821	$583K
70496		<1%	2,065	$578K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	8,135	$570K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,447	$566K
86900		<1%	18,197	$563K
99238	Hospital discharge day management, 30 minutes or less	<1%	9,136	$556K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	25,510	$535K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	15,248	$516K
73110		<1%	8,265	$500K
76770		<1%	9,218	$497K
73630		<1%	12,115	$493K
72110		<1%	5,942	$490K
J0897	Injection, denosumab, 1 mg	<1%	1,010	$489K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	3,739	$488K
88342		<1%	17,229	$477K
88307		<1%	7,853	$476K
73610		<1%	8,987	$458K
29848		<1%	505	$449K
77334		<1%	442	$442K
73130		<1%	7,803	$440K
73030		<1%	13,723	$438K
43248		<1%	835	$436K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,624	$422K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	17,088	$422K
74183		<1%	1,702	$421K
00731		<1%	2,963	$417K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	4,956	$414K
83970		<1%	5,298	$411K
84403		<1%	3,783	$407K
77066	Tomosynthesis, mammo	<1%	5,991	$401K
99201		<1%	18,637	$400K
93976		<1%	11,191	$389K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,435	$387K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,912	$383K
76801		<1%	4,838	$380K
90792	Psychiatric diagnostic evaluation with medical services	<1%	3,780	$361K
83036	Hemoglobin; glycosylated (A1C)	<1%	49,297	$342K
99223	Prolong inpt eval add15 m	<1%	3,477	$325K
00811		<1%	2,557	$315K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	544	$314K
73560		<1%	7,383	$295K
94060		<1%	1,395	$288K
90677		<1%	2,216	$286K
73221		<1%	2,444	$283K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	474	$280K
76830	Ultrasound, transvaginal	<1%	17,866	$276K
77412		<1%	2,469	$276K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	2,241	$272K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	2,002	$264K
93798		<1%	3,120	$261K
73562		<1%	9,451	$255K
72100		<1%	5,500	$252K
93970		<1%	2,392	$246K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	41	$243K
72131		<1%	1,335	$241K
77427		<1%	2,092	$234K
73564		<1%	3,014	$233K
77063	Screening digital breast tomosynthesis, bilateral	<1%	30,075	$229K
96415		<1%	2,807	$228K
95117		<1%	7,612	$226K
44970		<1%	41	$219K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	3,445	$218K
77065	Tomosynthesis, mammo	<1%	6,521	$217K
36430		<1%	2,659	$216K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	45,783	$215K
99219		<1%	3,224	$212K
31575		<1%	1,900	$208K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,208	$208K
90832	Psychotherapy session, about 30 minutes	<1%	3,392	$197K
71045	Radiologic examination, chest; single view	<1%	56,461	$197K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	564	$194K
77385		<1%	708	$192K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	224	$191K
80074		<1%	3,950	$190K
86003		<1%	2,470	$189K
74018		<1%	7,486	$185K
93454		<1%	162	$182K
76818		<1%	3,006	$182K
71250		<1%	3,723	$178K
72141		<1%	1,121	$178K
58301		<1%	571	$177K
J7300	Intrauterine copper contraceptive (paragard)	<1%	144	$174K
93971		<1%	4,484	$172K
73502		<1%	5,784	$168K
77014		<1%	7,186	$165K
58670		<1%	38	$165K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,658	$162K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	22,198	$159K
0450	Emergency room services	<1%	3,163	$157K
36561		<1%	87	$156K
88341		<1%	4,081	$154K
30520		<1%	62	$152K
90834	Psychotherapy session, about 45 minutes	<1%	1,635	$151K
87625		<1%	1,032	$151K
74174		<1%	484	$149K
76870		<1%	2,894	$147K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	2,063	$139K
70486		<1%	2,800	$139K
69210		<1%	2,566	$139K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,969	$138K
99217		<1%	3,716	$137K
77012		<1%	184	$129K
91200		<1%	1,987	$128K
73140		<1%	2,467	$127K
90671		<1%	1,985	$125K
31231		<1%	882	$124K
84146		<1%	4,233	$123K
73080		<1%	3,035	$123K
52000		<1%	900	$122K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	47	$120K
94010		<1%	1,114	$120K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	364	$116K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	170	$115K
72197		<1%	496	$114K
73590		<1%	4,156	$113K
72050		<1%	2,158	$111K
74170		<1%	583	$109K
83690		<1%	51,815	$109K
74246		<1%	730	$108K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	206,775	$105K
72170		<1%	3,282	$103K
90791	Psychiatric diagnostic evaluation	<1%	1,028	$99K
76642		<1%	1,295	$99K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,332	$97K
H0031	Mental health assessment, by non-physician	<1%	696	$94K
72040		<1%	2,315	$94K
77049		<1%	260	$93K
96361	Intravenous infusion, hydration; each additional hour	<1%	16,258	$93K
72082		<1%	927	$92K
78306		<1%	451	$91K
95816		<1%	520	$91K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	9,724	$91K
73090		<1%	3,206	$88K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	16,103	$87K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,562	$86K
43235		<1%	174	$83K
80048	Basic metabolic panel (calcium, ionized)	<1%	42,463	$83K
84702		<1%	10,371	$81K
83013		<1%	2,209	$81K
93880		<1%	1,532	$79K
86803		<1%	8,016	$78K
96375	Therapeutic injection; each additional sequential IV push	<1%	42,117	$78K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	202	$78K
J3489	Injection, zoledronic acid, 1 mg	<1%	1,202	$78K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	14,289	$75K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	9,362	$74K
90651		<1%	3,024	$73K
70491		<1%	745	$72K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	1,319	$72K
99243		<1%	874	$70K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	7,357	$69K
96523		<1%	1,772	$68K
74019		<1%	1,600	$66K
82607		<1%	10,598	$66K
30901		<1%	533	$65K
73620		<1%	1,761	$65K
90670		<1%	8,998	$61K
99220		<1%	785	$61K
20550		<1%	226	$60K
51729		<1%	97	$59K
99254		<1%	484	$59K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,226	$58K
51702		<1%	2,518	$57K
88141		<1%	2,497	$57K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,271	$56K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	9,252	$56K
59400	Routine obstetric care including antepartum care, vaginal delivery, and postpartum care	<1%	36	$56K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	116	$56K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	669	$55K
73552		<1%	2,383	$55K
C1874	Stent, coated/covered, with delivery system	<1%	403	$54K
83880		<1%	24,511	$54K
72070		<1%	1,553	$54K
A4648	Tissue marker, implantable, any type, each	<1%	691	$54K
11043		<1%	260	$53K
76820		<1%	4,244	$53K
76942		<1%	812	$51K
76882		<1%	738	$50K
88304		<1%	10,025	$49K
58100		<1%	211	$49K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	189	$49K
81511		<1%	619	$49K
73000		<1%	643	$48K
84153		<1%	3,543	$48K
84443	Thyroid stimulating hormone (TSH)	<1%	49,454	$48K
82378		<1%	2,213	$48K
73700		<1%	580	$48K
99205	Prolong outpt/office vis	<1%	537	$47K
92134		<1%	2,523	$47K
73521		<1%	1,580	$46K
73060		<1%	1,853	$46K
95115		<1%	1,481	$46K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	64	$45K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	628	$45K
20606		<1%	161	$45K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	4,080	$45K
10060		<1%	856	$44K
82533		<1%	1,704	$41K
87086	Culture, bacterial; quantitative colony count, urine	<1%	56,372	$40K
76813		<1%	1,242	$40K
76821		<1%	2,857	$39K
99462		<1%	1,237	$38K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	1,701	$38K
73565		<1%	1,515	$38K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	948	$38K
80069		<1%	7,234	$37K
82728		<1%	11,121	$37K
92504		<1%	9,473	$36K
88185		<1%	183	$35K
51798		<1%	2,168	$35K
87507		<1%	255	$35K
81001		<1%	105,533	$34K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	158	$33K
80061	Lipid panel	<1%	44,823	$33K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	404	$32K
86480		<1%	777	$31K
73070		<1%	964	$31K
00813		<1%	234	$30K
74022		<1%	7,140	$30K
96411		<1%	683	$30K
99255		<1%	178	$29K
95819		<1%	168	$29K
73100		<1%	605	$29K
J1756	Injection, iron sucrose, 1 mg	<1%	4,124	$29K
71270		<1%	309	$29K
76881		<1%	358	$29K
43775		<1%	36	$28K
J1453	Injection, fosaprepitant, 1 mg	<1%	831	$28K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	13,553	$27K
74230		<1%	254	$27K
82950		<1%	3,665	$26K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	3,495	$26K
J0490	Injection, belimumab, 10 mg	<1%	29	$26K
99381		<1%	417	$26K
11982		<1%	75	$24K
70498		<1%	1,985	$24K
87046		<1%	2,818	$24K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	43,629	$24K
78227		<1%	62	$24K
90837	Psychotherapy session, about an hour	<1%	311	$23K
87340		<1%	7,342	$23K
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	<1%	2,857	$23K
93925		<1%	259	$22K
87186		<1%	16,604	$22K
92557		<1%	5,024	$22K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,472	$22K
86800		<1%	1,611	$22K
74241		<1%	111	$21K
85027		<1%	55,010	$21K
43244		<1%	25	$21K
25600		<1%	139	$20K
74220		<1%	183	$20K
84480		<1%	3,871	$20K
72158		<1%	98	$20K
84484		<1%	76,988	$20K
87522	Neg quan hep c or qual rna	<1%	966	$20K
96417		<1%	2,213	$19K
82951		<1%	989	$19K
99225		<1%	678	$19K
87490		<1%	6,460	$19K
88112		<1%	2,091	$19K
97161		<1%	4,494	$19K
20600		<1%	112	$19K
29075		<1%	365	$19K
19081		<1%	12	$19K
20605		<1%	83	$18K
83520		<1%	3,266	$18K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	74	$18K
29125		<1%	1,290	$18K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,362	$18K
64483		<1%	26	$17K
83735		<1%	67,247	$17K
96367		<1%	7,702	$17K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	30	$17K
85730		<1%	34,290	$17K
76000		<1%	2,705	$17K
11750		<1%	44	$17K
73660		<1%	495	$17K
73600		<1%	526	$17K
92015	Determination of refractive state	<1%	818	$16K
0077U		<1%	702	$16K
70544		<1%	863	$16K
99499		<1%	246	$15K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,640	$15K
88361		<1%	123	$15K
99152		<1%	10,157	$15K
76377		<1%	213	$15K
75574		<1%	143	$14K
90619		<1%	639	$14K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	525	$14K
62323		<1%	119	$14K
87081		<1%	6,910	$14K
83655		<1%	1,955	$14K
77074		<1%	117	$14K
80320		<1%	13,071	$13K
12001		<1%	1,529	$13K
J1815	Injection, insulin, per 5 units	<1%	10,490	$13K
86920		<1%	1,662	$13K
97597		<1%	680	$12K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	5,088	$12K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	13	$12K
71271		<1%	383	$12K
84520		<1%	3,785	$12K
99253		<1%	142	$12K
84305		<1%	314	$12K
77338		<1%	67	$12K
95911		<1%	37	$12K
77300		<1%	922	$12K
71101		<1%	816	$11K
36821		<1%	13	$11K
97605		<1%	364	$11K
99218		<1%	212	$11K
00790		<1%	27	$11K
86850		<1%	18,014	$10K
38505		<1%	13	$10K
99221		<1%	193	$10K
84030		<1%	1,340	$10K
11044		<1%	26	$10K
99350	Prolong home eval add 15m	<1%	188	$10K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	3,758	$10K
99497		<1%	475	$10K
77001		<1%	1,298	$10K
80076		<1%	4,239	$10K
86334		<1%	322	$10K
C1769	Guide wire	<1%	10,673	$10K
86341		<1%	117	$10K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	331	$10K
87481		<1%	9,425	$10K
57454		<1%	477	$9K
36589		<1%	29	$9K
J2997	Injection, alteplase recombinant, 1 mg	<1%	17	$9K
J7030	Infusion, normal saline solution , 1000 cc	<1%	88,960	$9K
58300		<1%	1,053	$9K
81025		<1%	29,319	$9K
92083		<1%	161	$9K
J9171	Injection, docetaxel, 1 mg	<1%	47	$9K
84445		<1%	1,200	$9K
87653		<1%	2,788	$9K
85652		<1%	13,909	$9K
99442		<1%	384	$9K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	17	$8K
01961		<1%	25	$8K
77301		<1%	13	$8K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	33	$8K
93295		<1%	347	$8K
82274		<1%	2,012	$8K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	161	$8K
97116		<1%	4,449	$8K
85610		<1%	60,650	$8K
99226		<1%	176	$8K
82670		<1%	2,028	$8K
81003		<1%	64,974	$8K
19000		<1%	26	$8K
99235		<1%	93	$8K
88313		<1%	1,576	$8K
77263		<1%	67	$7K
83516		<1%	2,300	$7K
99463		<1%	95	$7K
88311		<1%	1,895	$7K
97803		<1%	134	$7K
90732		<1%	1,128	$7K
70360		<1%	249	$7K
86703		<1%	6,375	$7K
86255		<1%	1,148	$7K
85379		<1%	5,173	$7K
82962		<1%	107,436	$7K
93017		<1%	123	$7K
32555		<1%	120	$7K
99443		<1%	236	$7K
85060		<1%	395	$7K
87070		<1%	7,936	$7K
85018		<1%	8,443	$7K
00812		<1%	46	$7K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,342	$7K
77077		<1%	47	$7K
84134		<1%	1,080	$7K
82550		<1%	36,812	$6K
72072		<1%	298	$6K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	55	$6K
74240		<1%	27	$6K
82553		<1%	27,597	$6K
73120		<1%	85	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	817	$6K
97542		<1%	148	$6K
0251		<1%	1,874	$6K
81596		<1%	81	$6K
88374		<1%	30	$6K
92567		<1%	10,496	$6K
92586		<1%	44	$6K
72080		<1%	159	$6K
29515		<1%	204	$6K
82731		<1%	516	$6K
76376		<1%	302	$6K
95251		<1%	230	$6K
60100		<1%	12	$5K
82248		<1%	1,955	$5K
87077		<1%	19,522	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	8,928	$5K
86769		<1%	257	$5K
87075		<1%	4,692	$5K
87640		<1%	419	$5K
69209		<1%	79	$5K
29065		<1%	105	$5K
90734		<1%	1,440	$5K
12002		<1%	591	$5K
12011		<1%	813	$5K
72220		<1%	138	$5K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,490	$5K
99348		<1%	235	$5K
99245		<1%	27	$5K
93296		<1%	166	$5K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	891	$4K
67028	Intravitreal injection of a pharmacologic agent	<1%	85	$4K
80329		<1%	5,421	$4K
86923		<1%	450	$4K
90715		<1%	10,814	$4K
90710		<1%	4,582	$4K
93922		<1%	256	$4K
83001		<1%	3,241	$4K
30140		<1%	56	$4K
87040		<1%	16,270	$4K
83605		<1%	16,032	$4K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	393	$4K
52356		<1%	12	$4K
77290		<1%	12	$4K
90621		<1%	459	$4K
J3490	Unclassified drugs	<1%	968	$4K
92552		<1%	1,373	$4K
72128		<1%	210	$4K
87493		<1%	330	$4K
51797		<1%	228	$4K
87590		<1%	6,461	$4K
97760		<1%	72	$3K
82150		<1%	16,841	$3K
94729		<1%	935	$3K
90381		<1%	166	$3K
97162		<1%	1,793	$3K
84703		<1%	13,649	$3K
31500		<1%	190	$3K
76812		<1%	36	$3K
86235		<1%	251	$3K
88302		<1%	1,122	$3K
92610		<1%	673	$3K
99418	Prolong nursin fac eval 15m	<1%	76	$3K
G0008	Administration of influenza virus vaccine	<1%	2,645	$3K
83550		<1%	9,027	$3K
73650		<1%	41	$3K
87631		<1%	389	$3K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	1,302	$3K
99383		<1%	41	$3K
88312		<1%	446	$3K
86038		<1%	3,340	$3K
87209		<1%	502	$3K
82746		<1%	5,378	$3K
72146		<1%	51	$3K
84144		<1%	1,028	$3K
88360		<1%	12	$3K
11730		<1%	13	$3K
86592		<1%	13,611	$3K
87538		<1%	12	$3K
85007		<1%	8,291	$3K
0636		<1%	285	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	11,000	$3K
94726		<1%	690	$3K
36415	Collection of venous blood by venipuncture	<1%	344,395	$2K
86359		<1%	14	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	52,183	$2K
96380		<1%	270	$2K
82671		<1%	41	$2K
99349		<1%	69	$2K
29405		<1%	16	$2K
75716		<1%	28	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	39,560	$2K
P9021	Red blood cells, each unit	<1%	341	$2K
90380		<1%	141	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	21,747	$2K
82390		<1%	554	$2K
99385		<1%	28	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	50,142	$2K
29085		<1%	70	$2K
84132		<1%	2,805	$2K
84145		<1%	3,747	$2K
80051		<1%	85	$2K
99457		<1%	129	$2K
96376		<1%	11,263	$2K
01810		<1%	12	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	23,234	$2K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	33,644	$2K
29105		<1%	63	$2K
86870		<1%	42	$2K
82803		<1%	3,184	$2K
99454		<1%	56	$2K
77280		<1%	41	$2K
81050		<1%	1,469	$2K
92523		<1%	257	$2K
88184		<1%	181	$2K
36907		<1%	99	$2K
86696		<1%	469	$1K
93923		<1%	100	$1K
99242		<1%	25	$1K
87536		<1%	68	$1K
99441		<1%	147	$1K
86762		<1%	5,233	$1K
72192		<1%	39	$1K
84597		<1%	194	$1K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	1,046	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,913	$1K
94660		<1%	243	$1K
82570		<1%	6,082	$1K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,781	$1K
36620		<1%	50	$1K
85613		<1%	45	$1K
87581		<1%	1,564	$1K
87486		<1%	1,564	$1K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	9,659	$1K
86140		<1%	19,080	$1K
36416		<1%	83,373	$1K
87147		<1%	4,674	$1K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	463	$1K
82805		<1%	1,302	$1K
83883		<1%	29	$1K
96127		<1%	156	$1K
36600		<1%	1,189	$1K
86901		<1%	18,203	$1K
82140		<1%	2,762	$1K
87899		<1%	2,483	$1K
84100		<1%	11,871	$1K
72114		<1%	12	$997.91
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	5,075	$994.48
99336		<1%	49	$990.86
88720		<1%	369	$940.03
94727		<1%	222	$933.47
82043		<1%	6,738	$925.79
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	8,305	$916.23
87338		<1%	146	$913.25
82103		<1%	545	$905.99
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	15,318	$893.49
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,180	$880.45
95886		<1%	68	$868.88
82565		<1%	5,042	$865.87
82131		<1%	385	$852.87
J1170	Injection, hydromorphone, up to 4 mg	<1%	14,657	$834.98
95813		<1%	42	$828.22
99252		<1%	14	$816.64
71100		<1%	63	$810.04
77336		<1%	1,444	$806.25
99310	Prolong nursin fac eval 15m	<1%	12	$804.65
76857		<1%	18	$797.40
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	7,337	$791.34
82784		<1%	2,565	$745.85
82575		<1%	34	$743.35
93297		<1%	48	$733.83
99001		<1%	596	$729.27
92081		<1%	12	$727.36
73020		<1%	14	$726.08
92133		<1%	125	$717.07
84432		<1%	14	$712.90
82010		<1%	2,406	$705.38
J3370	Injection, vancomycin hcl, 500 mg	<1%	6,221	$693.17
82652		<1%	1,096	$670.82
16020		<1%	23	$640.19
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	9,274	$637.21
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	9,171	$633.47
84425		<1%	1,409	$619.38
86300		<1%	882	$596.31
96402		<1%	1,708	$576.44
G0379	Direct admission of patient for hospital observation care	<1%	76	$575.34
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	877	$575.25
70487		<1%	12	$564.20
83993		<1%	25	$564.06
84460		<1%	2,990	$546.44
87632		<1%	87	$541.94
J2550	Injection, promethazine hcl, up to 50 mg	<1%	7,473	$539.52
87529		<1%	152	$534.79
80202		<1%	997	$531.49
83615		<1%	7,326	$529.68
85397		<1%	12	$513.26
84550		<1%	3,259	$511.67
93294		<1%	30	$508.33
83540		<1%	11,067	$503.06
99241		<1%	18	$499.30
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,747	$497.35
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,306	$492.81
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	2,890	$492.49
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,538	$483.41
82985		<1%	1,060	$475.76
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	7,655	$474.67
92551		<1%	106	$465.92
87045		<1%	1,384	$465.58
84207		<1%	1,178	$453.65
93226		<1%	19	$449.72
11981		<1%	385	$425.46
97166		<1%	512	$416.25
85045		<1%	1,590	$413.93
77332		<1%	24	$409.84
76937		<1%	143	$402.72
J3480	Injection, potassium chloride, per 2 meq	<1%	6,486	$392.39
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	7,656	$360.02
83002		<1%	2,643	$356.17
C1729	Catheter, drainage	<1%	3,727	$354.12
J2704	Injection, propofol, 10 mg	<1%	27,250	$353.63
86376		<1%	2,813	$349.90
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	37,065	$346.94
J2060	Injection, lorazepam, 2 mg	<1%	5,718	$341.40
99417	Prolong home eval add 15m	<1%	25	$340.92
90633		<1%	6,043	$340.22
86200		<1%	1,708	$340.20
G0444	Annual depression screening, 5 to 15 minutes	<1%	797	$339.79
87177		<1%	492	$339.75
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	4,837	$328.17
90673		<1%	32	$326.16
82107		<1%	37	$320.94
J1644	Injection, heparin sodium, per 1000 units	<1%	13,232	$311.78
82024		<1%	910	$302.44
J1940	Injection, furosemide, up to 20 mg	<1%	6,550	$298.24
86706		<1%	1,344	$293.89
74420		<1%	28	$293.01
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	18	$290.83
87015		<1%	1,798	$290.42
86780		<1%	259	$288.85
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	3,777	$274.89
84450		<1%	2,991	$273.71
86635		<1%	212	$272.47
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	949	$268.85
96381		<1%	19	$267.82
77387		<1%	487	$264.35
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	21	$262.23
86141		<1%	1,236	$259.04
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,461	$250.40
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	5,487	$249.74
80164		<1%	90	$246.81
86364		<1%	221	$246.79
82627		<1%	1,697	$233.12
82105		<1%	1,564	$232.66
97165		<1%	2,591	$231.97
90662		<1%	1,908	$231.73
82947		<1%	5,655	$231.58
90686		<1%	11,783	$230.60
83014		<1%	608	$228.52
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	742	$227.90
82330		<1%	471	$207.93
86431		<1%	1,126	$193.35
93228		<1%	13	$192.16
85390		<1%	91	$186.46
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	5,579	$180.30
J7050	Infusion, normal saline solution, 250 cc	<1%	20,011	$179.06
0352U		<1%	351	$178.30
85651		<1%	4,142	$172.91
85014		<1%	5,465	$172.56
36591		<1%	46	$171.12
83525		<1%	361	$170.55
82088		<1%	27	$167.10
82785		<1%	1,340	$166.63
86316		<1%	263	$166.62
84156		<1%	6,305	$164.46
88300		<1%	292	$155.59
84481		<1%	7,505	$150.05
92556		<1%	93	$148.21
J0690	Injection, cefazolin sodium, 500 mg	<1%	15,148	$146.47
86593		<1%	99	$142.80
51741		<1%	130	$140.08
86147		<1%	62	$139.79
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,851	$129.90
90649		<1%	35	$129.85
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	4,243	$123.88
86430		<1%	1,006	$118.71
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	18,314	$115.59
83498		<1%	298	$114.41
J1953	Injection, levetiracetam, 10 mg	<1%	1,510	$109.71
84681		<1%	382	$108.49
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	4,024	$103.55
90685		<1%	443	$101.96
J1335	Injection, ertapenem sodium, 500 mg	<1%	3,696	$100.58
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	50	$96.84
J1630	Injection, haloperidol, up to 5 mg	<1%	1,572	$92.10
J3360	Injection, diazepam, up to 5 mg	<1%	733	$92.02
99490	Ccm add 20min	<1%	71	$88.90
A4314	Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	<1%	970	$88.68
74300		<1%	384	$83.19
86146		<1%	51	$81.88
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	4,282	$72.81
99153	Mod sedat endo service >5yrs	<1%	4,889	$70.75
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,758	$69.48
89051		<1%	826	$68.51
J1956	Injection, levofloxacin, 250 mg	<1%	3,830	$65.59
82104		<1%	495	$62.16
97535	Self-care/home management training, each 15 minutes	<1%	1,590	$61.95
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	5,834	$59.40
87102		<1%	82	$59.38
82525		<1%	273	$56.31
Q3014	Telehealth originating site facility fee	<1%	162	$55.85
80197		<1%	108	$55.46
87076		<1%	90	$55.15
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	2,378	$54.52
90680		<1%	7,992	$51.15
84436		<1%	1,283	$50.00
85049		<1%	1,723	$49.24
86694		<1%	407	$47.50
86812		<1%	40	$46.68
J0456	Injection, azithromycin, 500 mg	<1%	807	$46.34
82977		<1%	139	$45.68
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	84	$45.36
94002		<1%	65	$44.80
84630		<1%	288	$43.78
84255		<1%	132	$40.73
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	2,740	$39.72
85384		<1%	193	$39.64
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	2,630	$38.11
99406		<1%	866	$35.75
80177		<1%	13	$35.08
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	1,328	$33.96
86695		<1%	469	$33.62
G0009	Administration of pneumococcal vaccine	<1%	1,101	$32.90
87210		<1%	363	$32.56
95012		<1%	500	$31.75
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	398	$28.89
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	143	$28.09
84165		<1%	852	$27.26
83037		<1%	188	$26.56
84244		<1%	27	$25.36
A4353	Intermittent urinary catheter, with insertion supplies	<1%	1,256	$25.26
90656		<1%	1,147	$24.67
J0780	Injection, prochlorperazine, up to 10 mg	<1%	272	$23.73
90688		<1%	189	$22.08
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	469	$21.82
90697		<1%	3,154	$18.38
83935		<1%	42	$18.11
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	143	$15.80
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	159	$15.68
87420		<1%	203	$15.49
86704		<1%	238	$14.69
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	110	$14.17
J1790	Injection, droperidol, up to 5 mg	<1%	910	$14.10
86225		<1%	152	$13.94
93325		<1%	17	$13.08
84466		<1%	435	$13.06
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	1,672	$11.08
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	266	$10.32
94760		<1%	13	$10.17
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	<1%	375	$9.29
86308		<1%	83	$8.98
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	179	$8.78
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,472	$8.53
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	1,580	$8.04
99173		<1%	107	$6.83
J7612	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg	<1%	404	$6.30
82310		<1%	46	$5.24
J3535	Drug administered through a metered dose inhaler	<1%	338	$5.01
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,984	$4.61
84300		<1%	58	$4.32
J3411	Injection, thiamine hcl, 100 mg	<1%	602	$4.17
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	1,113	$3.00
84155		<1%	967	$2.96
J8540	Dexamethasone, oral, 0.25 mg	<1%	116	$2.80
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,340	$2.64
84157		<1%	109	$2.24
S0028	Injection, famotidine, 20 mg	<1%	2,876	$1.77
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	6,446	$1.17
90700		<1%	1,961	$1.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,022	$0.85
J7510	Prednisolone oral, per 5 mg	<1%	959	$0.48
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,484	$0.44
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	684	$0.16
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,022	$0.16
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	559	$0.07
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	307	$0.05
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,324	$0.04
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	132	$0.01
3074F		0%	69,315	$0.00
90647		0%	762	$0.00
3075F		0%	5,976	$0.00
3079F		0%	16,294	$0.00
3044F		0%	2,415	$0.00
1126F		0%	93,599	$0.00
90696		0%	1,924	$0.00
86160		0%	717	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	171	$0.00
82952		0%	821	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	1,374	$0.00
90698		0%	4,839	$0.00
90723		0%	2,018	$0.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	936	$0.00
90744		0%	1,878	$0.00
84402		0%	2,701	$0.00
84446		0%	227	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	372	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	2,046	$0.00
84154		0%	1,155	$0.00
86301		0%	25	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	442	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	97	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	233	$0.00
C1750	Catheter, hemodialysis/peritoneal, long-term	0%	16	$0.00
3080F		0%	201	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	316	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	86	$0.00
C1781	Mesh (implantable)	0%	531	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	631	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	297	$0.00
82945		0%	63	$0.00
90716		0%	58	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	1,235	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	440	$0.00
76872		0%	14	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	157	$0.00
86381		0%	340	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	346	$0.00
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	0%	32	$0.00
C2627	Catheter, suprapubic/cystoscopic	0%	190	$0.00
90622		0%	44	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	24	$0.00
83921		0%	89	$0.00
45381		0%	41	$0.00
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	0%	26	$0.00
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	0%	66	$0.00
90674		0%	70	$0.00
93797		0%	13	$0.00
C1884	Embolization protective system	0%	21	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	26	$0.00
64615		0%	12	$0.00
94644		0%	13	$0.00
J0611	Injection, calcium gluconate (wg critical care), per 10 ml	0%	25	$0.00
99407		0%	13	$0.00
J2358	Injection, olanzapine, long-acting, 1 mg	0%	26	$0.00
J3030	Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	0%	15	$0.00
J9045	Injection, carboplatin, 50 mg	0%	43	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	19	$0.00
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	0%	21	$0.00
0500F		0%	14	$0.00
3078F		0%	76,042	$0.00
1159F		0%	10,937	$0.00
90648		0%	2,858	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	989	$0.00
3077F		0%	7,459	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	233	$0.00
86708		0%	138	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	4,555	$0.00
C1758	Catheter, ureteral	0%	2,372	$0.00
C1788	Port, indwelling (implantable)	0%	55	$0.00
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	0%	62	$0.00
0502F		0%	2,430	$0.00
J0701	Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg	0%	98	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	26	$0.00
A4565	Slings	0%	1,119	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	2,941	$0.00
J3105	Injection, terbutaline sulfate, up to 1 mg	0%	64	$0.00
3051F		0%	81	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	72	$0.00
85347		0%	330	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	397	$0.00
86162		0%	26	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	256	$0.00
87641		0%	433	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	232	$0.00
83630		0%	58	$0.00
92611		0%	162	$0.00
90682		0%	82	$0.00
86360		0%	14	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	537	$0.00
90681		0%	140	$0.00
82180		0%	180	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	100	$0.00
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	0%	478	$0.00
90746		0%	157	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	361	$0.00
84112		0%	70	$0.00
84590		0%	264	$0.00
J2185	Injection, meropenem, 100 mg	0%	56	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	129	$0.00
J3486	Injection, ziprasidone mesylate, 10 mg	0%	28	$0.00
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	0%	125	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	45	$0.00
88325		0%	43	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	12	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	17	$0.00
51784		0%	50	$0.00
77002		0%	30	$0.00
70546		0%	13	$0.00
90707		0%	97	$0.00
90653		0%	73	$0.00
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	35	$0.00
93356		0%	65	$0.00
81002		0%	40	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	40	$0.00
J9000	Injection, doxorubicin hydrochloride, 10 mg	0%	39	$0.00
82232		0%	25	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	20	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	38	$0.00
85306		0%	14	$0.00
87535		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOORE, VERNON (SVP & CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under MOORE, VERNON

Full network →

Provider	Location	Paid
BRFHH Shreveport LLC	Shreveport, LA	$6.30M
University Health Shreveport LLC	Shreveport, LA	$2.60M
Yuma Regional Medical Center	Yuma, AZ	$1.18M
BRFHH Shreveport LLC	Shreveport, LA	$494K
University Health Shreveport LLC	Shreveport, LA	$350K
BRFHH Shreveport LLC	Shreveport, LA	$12K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.